Utah Medical Products Statistics
Share Statistics
Utah Medical Products has 3.25M
shares outstanding. The number of shares has increased by -6.99%
in one year.
| Shares Outstanding | 3.25M |
| Shares Change (YoY) | -6.99% |
| Shares Change (QoQ) | -3.24% |
| Owned by Institutions (%) | 66.04% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 128 |
| FTD / Avg. Volume | 0.73% |
Short Selling Information
The latest short interest is 86.97K, so 2.65% of the outstanding
shares have been sold short.
| Short Interest | 86.97K |
| Short % of Shares Out | 2.65% |
| Short % of Float | 3.27% |
| Short Ratio (days to cover) | 5.35 |
Valuation Ratios
The PE ratio is 15.52 and the forward
PE ratio is null.
Utah Medical Products's PEG ratio is
-1.16.
| PE Ratio | 15.52 |
| Forward PE | n/a |
| PS Ratio | 5.26 |
| Forward PS | 1.8 |
| PB Ratio | 1.83 |
| P/FCF Ratio | 0 |
| PEG Ratio | -1.16 |
Financial Ratio HistoryEnterprise Valuation
Utah Medical Products has an Enterprise Value (EV) of 132.64M.
| EV / Sales | 3.24 |
| EV / EBITDA | 8.07 |
| EV / EBIT | 0 |
| EV / FCF | 0 |
Financial Position
The company has a current ratio of 25.64,
with a Debt / Equity ratio of 0.
| Current Ratio | 25.64 |
| Quick Ratio | 23.29 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 11.81% and Return on Invested Capital is 9.45%.
| Return on Equity | 11.81% |
| Return on Assets | 11.32% |
| Return on Invested Capital | 9.45% |
| Revenue Per Employee | $263,890.32 |
| Profits Per Employee | $89,509.68 |
| Employee Count | 155 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.9 |
Taxes
| Income Tax | 2.93M |
| Effective Tax Rate | 17.43% |
Stock Price Statistics
The stock price has increased by -20.62% in the
last 52 weeks. The beta is 0.3, so Utah Medical Products's
price volatility has been higher than the market average.
| Beta | 0.3 |
| 52-Week Price Change | -20.62% |
| 50-Day Moving Average | 54.58 |
| 200-Day Moving Average | 61.72 |
| Relative Strength Index (RSI) | 44.41 |
| Average Volume (20 Days) | 17,539 |
Income Statement
In the last 12 months, Utah Medical Products had revenue of 40.9M
and earned 13.87M
in profits. Earnings per share was 3.96.
| Revenue | 40.9M |
| Gross Profit | 24.14M |
| Operating Income | 13.59M |
| Net Income | 13.87M |
| EBITDA | 16.44M |
| EBIT | 13.59M |
| Earnings Per Share (EPS) | 3.96 |
Full Income StatementBalance Sheet
The company has 82.98M in cash and 282K in
debt, giving a net cash position of 82.69M.
| Cash & Cash Equivalents | 82.98M |
| Total Debt | 282K |
| Net Cash | 82.69M |
| Retained Earnings | 129.3M |
| Total Assets | 122.52M |
| Working Capital | 92.08M |
Full Balance SheetMargins
Gross margin is 59.03%, with operating and profit margins of 33.23% and 33.92%.
| Gross Margin | 59.03% |
| Operating Margin | 33.23% |
| Pretax Margin | 41.08% |
| Profit Margin | 33.92% |
| EBITDA Margin | 40.19% |
| EBIT Margin | 33.23% |
| FCF Margin | n/a |
